Does fecal calprotectin reflect neutrophil-driven intestinal inflammation and typically rise in IBD?

Fecal calprotectin is an established, non-invasive biomarker that serves as a direct proxy for neutrophil-driven intestinal inflammation. Its clinical utility is particularly pronounced in the diagnosis and monitoring of inflammatory bowel disease (IBD).

Clinical and diagnostic evidence

Fecal calprotectin (FC) demonstrates high diagnostic accuracy for distinguishing IBD from non-inflammatory conditions like irritable bowel syndrome (IBS).

• Sensitivity and Specificity: Meta-analyses report a pooled sensitivity of approximately 92.5% and specificity of 85.1% for detecting IBD.
• Predictive Value: The biomarker is most valued for its negative predictive value (>90%), where levels below 50 μg/g effectively rule out active IBD.
• Disease Activity: In active Ulcerative Colitis or Crohn’s Disease, median FC levels often exceed 400–500 μg/g, significantly higher than the levels seen in functional gastrointestinal disorders. Thresholds above 150–250 μg/g are strongly associated with mucosal inflammation or a high risk of clinical relapse.

Mechanistic explanations

The elevation of fecal calprotectin is a direct consequence of the inflammatory cascade within the gut mucosa:

• Neutrophil Recruitment: During active IBD, neutrophils migrate across the intestinal epithelium toward the lumen in response to tissue damage.
• Protein Release: Calprotectin is a calcium-binding protein that constitutes roughly 60% of the cytosolic protein content in neutrophils. It is released into the stool via degranulation, cell death, or the formation of neutrophil extracellular traps (NETs).
• Histological Correlation: Evidence shows a strong positive correlation between fecal calprotectin levels and the density of histological neutrophil infiltration in both the epithelium and the lamina propria. Unlike systemic markers (e.g., C-reactive protein), FC levels are proportional to localized mucosal inflammation.

Bottom line

Fecal calprotectin is a highly sensitive indicator of neutrophil migration into the gut, making it typically and significantly elevated in inflammatory bowel disease compared to non-inflammatory states.